{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:49:00Z","timestamp":1790740140385,"version":"4.1.0"},"reference-count":30,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1248\/bpb.b19-00957","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T22:04:42Z","timestamp":1583013882000},"page":"569-573","source":"Crossref","is-referenced-by-count":22,"title":["Trimethylamine-&lt;i&gt;N&lt;\/i&gt;-oxide Specifically Impairs Endothelium-Derived Hyperpolarizing Factor-Type Relaxation in Rat Femoral Artery"],"prefix":"10.1248","volume":"43","author":[{"given":"Takayuki","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoka","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Spencer SP, Fragiadakis GK, Sonnenburg JL. Pursuing human-relevant gut microbiota-immune interactions. <i>Immunity<\/i>, <b>51<\/b>, 225\u2013239 (2019).","DOI":"10.1016\/j.immuni.2019.08.002"},{"key":"2","unstructured":"2) Jia Q, Xie Y, Lu C, Zhang A, Lu Y, Lv S, Zhang J. Endocrine organs of cardiovascular diseases: gut microbiota. <i>J. Cell. Mol. Med.<\/i>, <b>23<\/b>, 2314\u20132323 (2019)."},{"key":"3","unstructured":"3) Durack J, Lynch SV. The gut micribiome: Relationships with disease and opportunities for therapy. <i>J. Exp. Med.<\/i>, <b>216<\/b>, 20\u201340 (2019)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Brial F, Le Lay A, Dumas ME, Gauguier D. Implication of gut microbiota metabolites in cardiovascular and metabolic disease. <i>Cell. Mol. Life Sci.<\/i>, <b>75<\/b>, 3977\u20133990 (2018).","DOI":"10.1007\/s00018-018-2901-1"},{"key":"5","unstructured":"5) Cosola C, Rocchetti MT, Cupisti A, Gesualdo L. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease. <i>Pharmacol. Res.<\/i>, <b>130<\/b>, 132\u2013142 (2018)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kitai T, Tang WHW. Gut microbiota in cardiovascular disease and heart failure. <i>Clin. Sci.<\/i>, <b>132<\/b>, 85\u201391 (2018).","DOI":"10.1042\/CS20171090"},{"key":"7","unstructured":"7) Janeiro MH, Ramires MJ, Milagro FI, Martinez JA, Solas M. Implication of trimethylamine <i>N<\/i>-oxide (TMAO) in disease: potential biomarker or new therapeutic target. <i>Nutrients<\/i>, <b>10<\/b>, E1398 (2018)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-<i>N<\/i>-oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. <i>J. Am. Heart Assoc.<\/i>, <b>6<\/b>, e006347 (2017).","DOI":"10.1161\/JAHA.117.006347"},{"key":"9","unstructured":"9) Ma G, Pan B, Chen Y, Guo C, Zhao M, Zheng L, Chen B. Trimethylamine <i>N<\/i>-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion. <i>Biosci. Rep.<\/i>, <b>37<\/b>, BSR20160244 (2017)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, Lusis AJ, Shih DM. Trimethylamine <i>N<\/i>-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. <i>J. Am. Heart Assoc.<\/i>, <b>5<\/b>, e002767 (2016).","DOI":"10.1161\/JAHA.115.002767"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease \u2014 a 30th anniversary update. <i>Acta Physiol <\/i>(Oxf.)<i>.<\/i>, <b>219<\/b>, 22\u201396 (2017).","DOI":"10.1111\/apha.12646"},{"key":"12","unstructured":"12) Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. <i>Br. J. Pharmacol.<\/i>, <b>172<\/b>, 3980\u20134001 (2015)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Matsumoto T, Takayanagi K, Kojima M, Taguchi K, Kobayashi T. Acute exposure to indoxyl sulfate impairs endothelium-dependent vasorelaxation in rat aorta. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, E338 (2019).","DOI":"10.3390\/ijms20020338"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Matsumoto T, Takayanagi K, Kojima M, Katome T, Taguchi K, Kobayashi T. Direct impairment of the endothelial function by acute indoxyl sulfate through declined nitric oxide and not endothelium-deprived hyperpolarizing factor or vasodilator prostaglandins in rat superior mesenteric artery. <i>Biol. Pharm. Bull.<\/i>, <b>42<\/b>, 1236\u20131242 (2019).","DOI":"10.1248\/bpb.b19-00177"},{"key":"15","unstructured":"15) Matsumoto T, Watanabe S, Iguchi M, Ando M, Oda M, Nagata M, Yamada K, Taguchi K, Kobayashi T. Mechanisms underlying enhanced noradrenaline-induced femoral arterial contractions of spontaneously hypertensive rats: involved of endothelium-derived factors and cyclooxygenase-derived prostanoids. <i>Biol. Pharm. Bull.<\/i>, <b>39<\/b>, 384\u2013393 (2016)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Watanabe S, Matsumoto T, Ando M, Kobayashi S, Iguchi M, Taguchi K, Kobayashi T. A comparative study of vasorelaxant effects of ATP, ADP, and adenosine on the superior mesenteric artery of SHR. <i>Biol. Pharm. Bull.<\/i>, <b>39<\/b>, 1374\u20131380 (2016).","DOI":"10.1248\/bpb.b16-00260"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Singh GB, Zhang Y, Boini KM, Koka S. High mobility group box 1 mediates TMAO-induced endothelial dysfunction. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, E3570 (2019).","DOI":"10.3390\/ijms20143570"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Li T, Chen Y, Gua C, Li X. Elevated circulating trimethylamine <i>N<\/i>-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress. <i>Front. Physiol.<\/i>, <b>8<\/b>, 350 (2017).","DOI":"10.3389\/fphys.2017.00350"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Matsumoto T, Kobayashi T, Kamata K. Alterations in EDHF-type relaxation and phosphodiesterase activity in mesenteric arteries from diabetic rats. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>285<\/b>, H283\u2013H291 (2003).","DOI":"10.1152\/ajpheart.00954.2002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. <i>Clin. Exp. Pharmacol. Physiol.<\/i>, <b>31<\/b>, 641\u2013649 (2004).","DOI":"10.1111\/j.1440-1681.2004.04053.x"},{"key":"21","unstructured":"21) Garland CJ, Dora KA. EDH: endothelium-dependent hyperpolarization and microvascular signalling. <i>Acta Physiol. <\/i>(Oxf.), <b>219<\/b>, 152\u2013161 (2017)."},{"key":"22","unstructured":"22) Feletou M, Vanhoutte PM. EDHF: an update. <i>Clin. Sci.<\/i>, <b>117<\/b>, 139\u2013155 (2009)."},{"key":"23","unstructured":"23) Fleming I. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling. <i>Vascul. Pharmacol.<\/i>, <b>86<\/b>, 31\u201340 (2016)."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Shi Y, Ku DD, Man RY, Vanhoutte PM. Augmented endothelium-derived hyperpolarizing factor-mediated relaxations attenuate endothelial dysfunction in femoral and mesenteric but not in carotid arteries from type I diabetic rats. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>318<\/b>, 276\u2013281 (2006).","DOI":"10.1124\/jpet.105.099739"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sandow SL, Tare M, Coleman HA, Hill CE, Parkington HC. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. <i>Circ. Res.<\/i>, <b>90<\/b>, 1108\u20131113 (2002).","DOI":"10.1161\/01.RES.0000019756.88731.83"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Senthong V, Wang Z, Fan Y, Wu Y, Hazen SL, Thang WH. Trimethylamine <i>N<\/i>-oxide and mortality risk in patients with peripheral artery disease. <i>J. Am. Heart Assoc.<\/i>, <b>5<\/b>, e004237 (2016).","DOI":"10.1161\/JAHA.116.004237"},{"key":"27","unstructured":"27) Li XS, Obeid S, Klingenberg R, <i>et al.<\/i> Gut microbiota-dependent trimethylamine <i>N<\/i>-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. <i>Eur. Heart J.<\/i>, <b>38<\/b>, 814\u2013824 (2017)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Stubbs JR, House JA, Ocque AJ, Zhang S, Johnson C, Kimber C, Schmidt K, Gupta A, Wetmore JB, Nolin TD, Spertus JA, Yu AS. Serum trimethylamine-<i>N<\/i>-oxide is elevated in CKD and correlates with coronary atherosclerosis burden. <i>J. Am. Soc. Nephrol.<\/i>, <b>27<\/b>, 305\u2013313 (2016).","DOI":"10.1681\/ASN.2014111063"},{"key":"29","unstructured":"29) Martinez AC, Hernandez M, Novella S, Martinez MP, Pagan RM, Hermenegildo C, Garcia-Sacristan A, Prieto D, Benedito S. Diminished neurogenic femoral artery vasoconstrictor response in a Zucker obese rat model: differential regulation of NOS and COX derivatives. <i>PLOS ONE<\/i>, <b>9<\/b>, e106372 (2014)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Puzservova A, Kopincova J, Slezak P, Balis P, Bernatova I. Endothelial dysfunction in femoral artery of the hypertensive rats is nitric oxide independent. <i>Physiol. Res.<\/i>, <b>62<\/b>, 615\u2013629 (2013).","DOI":"10.33549\/physiolres.932517"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/3\/43_b19-00957\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T21:12:27Z","timestamp":1614633147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/3\/43_b19-00957\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00957","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}